Literature DB >> 31971148

Limited Awareness of Hepatitis B but Widespread Recognition of Its Sequelae in Rural Senegal: A Qualitative Study.

Sokhna Boye1, Yusuke Shimakawa2, Muriel Vray1,3, Tamara Giles-Vernick4.   

Abstract

To achieve the WHO's global strategy of eliminating hepatitis B virus (HBV) infection, it is essential to ensure adequate understanding of hepatitis B disease to facilitate uptake of screening, linkage to care, and adherence to antiviral therapy. Sub-Saharan Africa has the world's highest prevalence of HBV infection, yet less than 1% of HBV-infected people have been diagnosed. Lay populations do not widely recognize "hepatitis B." Hypothesizing that visible signs and symptoms of chronic HBV infection sequelae (jaundice, ascites, or cachexia) might be more easily recognizable, we conducted a qualitative study to determine how rural populations in Senegal understood these sequelae. We led six focus groups and 149 individual interviews with lay populations and formal and informal health workers in three rural study sites in Senegal. Only a third of lay populations (30/105) had ever heard of "hepatitis B," nor did they evoke local language diagnostic terms resembling this illness. Nevertheless, more than two-thirds (71/105) recognized signs and symptoms of end-stage liver disease but considered these physical manifestations to be a consequence of the manipulation of occult forces. Lay populations also contended that traditional healers, not formal medical structures, should treat such illnesses. Formal and informal health workers had limited knowledge about hepatitis B and difficulties identifying terms in local languages to explain the disease. Communication strategies based on the population's widespread recognition of the hepatitis sequelae may enhance awareness of hepatitis, which is a crucial element to increase screening uptake, linkage to care, and commitment to lifelong treatment in African communities.

Entities:  

Mesh:

Year:  2020        PMID: 31971148      PMCID: PMC7056417          DOI: 10.4269/ajtmh.19-0477

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  28 in total

1.  What can critical medical anthropology contribute to global health? A health systems perspective.

Authors:  James Pfeiffer; Mark Nichter
Journal:  Med Anthropol Q       Date:  2008-12

2.  Improving communication about viral hepatitis in Africa.

Authors:  Yusuke Shimakawa; Dolorès Pourette; Louis Bainilago; Catherine Enel; Roger Sombié; Ramanampamonjy Rado; Maud Lemoine; Tamara Giles-Vernick
Journal:  Lancet Infect Dis       Date:  2017-06-21       Impact factor: 25.071

3.  Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia.

Authors:  Yusuke Shimakawa; Maud Lemoine; Harr Freeya Njai; Christian Bottomley; Gibril Ndow; Robert D Goldin; Abdoulie Jatta; Adam Jeng-Barry; Rita Wegmuller; Sophie E Moore; Ignatius Baldeh; Makie Taal; Umberto D'Alessandro; Hilton Whittle; Ramou Njie; Mark Thursz; Maimuna Mendy
Journal:  Gut       Date:  2015-07-16       Impact factor: 23.059

4.  Knowledge of Hepatitis B Transmission Risks Among Health Workers in Tanzania.

Authors:  Jose D Debes; Johnstone Kayandabila; Hope Pogemiller
Journal:  Am J Trop Med Hyg       Date:  2016-02-29       Impact factor: 2.345

5.  Viral Hepatitis and a Hospital Infrastructure in Ruins in Cameroon.

Authors:  Fanny Chabrol
Journal:  Med Anthropol       Date:  2018-11-14

Review 6.  The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa.

Authors:  C F Kiire
Journal:  Gut       Date:  1996       Impact factor: 23.059

Review 7.  Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

Authors:  Aparna Schweitzer; Johannes Horn; Rafael T Mikolajczyk; Gérard Krause; Jördis J Ott
Journal:  Lancet       Date:  2015-07-28       Impact factor: 79.321

8.  Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries.

Authors:  Azumi Ishizaki; Julie Bouscaillou; Niklas Luhmann; Stephanie Liu; Raissa Chua; Nick Walsh; Sarah Hess; Elena Ivanova; Teri Roberts; Philippa Easterbrook
Journal:  BMC Infect Dis       Date:  2017-11-01       Impact factor: 3.090

9.  Prevalence and associated knowledge of hepatitis B infection among healthcare workers in Freetown, Sierra Leone.

Authors:  Yu-Ling Qin; Bo Li; Yue-Su Zhou; Xin Zhang; Lei Li; Bing Song; Peng Liu; Yue Yuan; Zhong-Peng Zhao; Jun Jiao; Jing Li; Yi Sun; Stephen Sevalie; Joseph E Kanu; Ya-Jun Song; Jia-Fu Jiang; Foday Sahr; Tian-Jun Jiang
Journal:  BMC Infect Dis       Date:  2018-07-09       Impact factor: 3.090

10.  The prevalence and burden of symptoms in patients with chronic liver diseases in The Gambia, West Africa.

Authors:  Yusuke Shimakawa; Yuki Takao; Suzanne T Anderson; Makie Taal; Takashi Yamaguchi; Lamin Giana; Gibril Ndow; Louise Sarr; Abubacarr Kambi; Harr Freeya Njai; Christian Bottomley; Ousman Nyan; Saihou Sabally; Umberto D'Alessandro; Simon D Taylor-Robinson; Mark Thursz; Maud Lemoine; Ramou Njie
Journal:  Palliat Med       Date:  2014-09-05       Impact factor: 4.762

View more
  4 in total

1.  The Waiting Room Project: An Approach to Community Health Education in Hepatitis B.

Authors:  Nasreen S Quadri; Jose D Debes
Journal:  Am J Trop Med Hyg       Date:  2020-07       Impact factor: 2.345

2.  Filtering Inequality: Screening and Knowledge in Senegal's Topography of Hepatitis B Care.

Authors:  Noemi Tousignant
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

3.  Applying the health capability profile to empirically study chronic hepatitis B in rural Senegal: a social justice mixed-methods study protocol.

Authors:  Marion Coste; Mouhamed Ahmed Badji; Aldiouma Diallo; Marion Mora; Sylvie Boyer; Jennifer J Prah
Journal:  BMJ Open       Date:  2022-04-11       Impact factor: 2.692

4.  Impact of Introducing Hepatitis B Birth Dose Vaccines into the Infant Immunization Program in Burkina Faso: Study Protocol for a Stepped Wedge Cluster Randomized Trial (NéoVac Study).

Authors:  Haoua Tall; Pierrick Adam; Abdoul Salam Eric Tiendrebeogo; Jeanne Perpétue Vincent; Laura Schaeffer; Cassandre von Platen; Sandrine Fernandes-Pellerin; François Sawadogo; Alkadri Bokoum; Ghislain Bouda; Seydou Ouattara; Issa Ouédraogo; Magali Herrant; Pauline Boucheron; Appolinaire Sawadogo; Edouard Betsem; Alima Essoh; Lassané Kabore; Amariane Ouattara; Nicolas Méda; Hervé Hien; Andréa Gosset; Tamara Giles-Vernick; Sylvie Boyer; Dramane Kania; Muriel Vray; Yusuke Shimakawa
Journal:  Vaccines (Basel)       Date:  2021-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.